This paper revisits the fractional cointegrating relationship between ex-ante implied volatility and ex-post realized volatility. We argue that the concept of corridor implied volatility (CIV) should be used instead of the popular model-free option-implied volatility (MFIV) when assessing the fractional cointegrating relation as the latter may introduce bias to the estimation. For the realized volatility, we use recently proposed methods which are robust to noise as well as jumps and interestingly we find that it does not affect the implied-realized volatility relation. In addition, we develop a new tool for the estimation of fractional cointegrating relation between implied and realized volatility based on wavelets, a wavelet band least squares (WBLS). The main advantage of WBLS in comparison to other frequency domain methods is that it allows us to work conveniently with potentially non-stationary volatility due to the properties of wavelets. We study the dynamics of the relationship in the time-frequency domain with the wavelet coherence confirming that the dependence comes solely from the lower frequencies of the spectra. Motivated by this result we estimate the relationship only on this part of the spectra using WBLS and compare our results to the fully modified narrow-band least squares (FMNBLS) based on the Fourier frequencies. In the estimation, we use the S&P 500 and DAX monthly and bi-weekly option prices covering the recent financial crisis and we conclude that in the long-run, volatility inferred from the option prices using the corridor implied volatility (CIV) provides an unbiased forecast of the realized volatility.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.